Prevalence of Myositis-Specific Autoantibodies and Myositis-Associated Autoantibodies in COVID-19 Patients: A Pilot Study and Literature Review

por Swartzman, Isaac, Gu, Juan J, Toner, Zachary, Grover, Raminder, Suresh, Lakshmanan, Ullman, Lori E
Publicado 2022

Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells

por Gu, Juan J., Kaufman, Gregory P., Mavis, Cory, Czuczman, Myron S, Hernand ez-Ilizaliturri, Francisco J.
Publicado 2016

Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma

por Singh, Anil R., Gu, Juan J., Zhang, Qunling, Torka, Pallawi, Sundaram, Suchitra, Mavis, Cory, Hernandez-Ilizaliturri, Francisco J.
Publicado 2020

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma

por Qiu, Shi, Liu, Yizhen, Gui, Ailing, Xia, Zuguang, Liu, Wen, Gu, Juan J., Zuo, Ji, Yang, Ling, Zhang, Qunling
Publicado 2022

Successful treatment of an 82‐year‐old COVID‐19 delta variant‐infected patient with haemorrhagic stroke and active prostate cancer brain metastasis

por Wang, Buhai, Yu, Jiangquan, Zeng, Yichun, Zhang, Xian, Han, Chongxu, Lu, Qili, Wang, Xiaolin, Liang, Yichen, Gu, Juan J., Shu, Yusheng
Publicado 2022

Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non‐small cell lung cancer patients with recurrence or metastasis: A s...

por Zeng, Yichun, Zhang, Liying, Liang, Yichen, Zhang, Xian, Li, Lei, Wang, Maoqi, Guo, Jingliang, Li, Qiuxian, Cao, Jin, Gu, Juan J., Wang, Buhai
Publicado 2023

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

por Jin, Jia, Ji, Dongmei, Xia, Zuguang, Xue, Kai, Zhang, Qunling, Liu, Yizhen, Cao, Junning, Hong, Xiaonan, Gu, Juan J., Guo, Ye, Lv, Fangfang
Publicado 2022

Development and Testing of an Intelligent Pain Management System (IPMS) on Mobile Phones Through a Randomized Trial Among Chinese Cancer Patients: A New Approach in Cancer Pain Man...

por Sun, Yunheng, Jiang, Feng, Gu, Juan J, Wang, Y Ken, Hua, Hongwei, Li, Jing, Cheng, Zhijun, Liao, Zhijun, Huang, Qian, Hu, Weiwei, Ding, Gang
Publicado 2017

Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development

por Gu, Juan J., Singh, Anil, Xue, Kai, Mavis, Cory, Barth, Matthew, Yanamadala, Vivek, Lenz, Peter, Grau, Michael, Lenz, Georg, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.
Publicado 2017

Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor

por Ji, Dongmei, Jiang, Shiyu, Zhang, Qunling, Wang, Y. Ken, Zhang, Jian, Shen, Weina, Li, Wenhua, Liu, Rujiao, Wang, Jessica, Mavis, Cory, Gu, Juan J., Hu, Xichun
Publicado 2023

Early Changes of Serum Interleukin 14α Levels Predicts the Response to Anti-PD-1 Therapy in Cancer

por Wang, Buhai, Chen, Caiyue, Jiang, Shiyu, Huang, Yuxiang, Zeng, Yichun, Li, Lei, Wang, Maoqi, Guo, Jingliang, Li, Qiuxian, Cao, Jin, Shen, Long, Gu, Juan J, Liang, Yichen
Publicado 2023

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial

por Xue, Kai, Gu, Juan J., Zhang, Qunling, Liu, Xiaojian, Wang, Jiachen, Li, Xiao-qiu, Luo, Jianfeng, Hernandez, Francisco J., Fernandez, Stanley F., Czuczman, Myron S., Cao, Junning, Hong, Xiaonan, Guo, Ye
Publicado 2016

Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy

por Goel, Shipra, Gu, Juan J., Torka, Pallawi, Mavis, Cory, Sundaram, Suchitra, Neiders, Mirdza, Suresh, Lakshmanan, Shen, Long, Ramsperger, Vince, Griffiths, Elizabeth A., Segal, Brahm, Hernandez-Ilizaliturri, Francisco J., Ghione, Paola
Publicado 2021

The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance

por Liu, Yizhen, Gu, Juan J., Yang, Ling, Tsai, Ping-Chiao, Guo, Ye, Xue, Kai, Xia, Zuguang, Liu, Xiaojian, Lv, Fangfang, Cao, Junning, Hong, Xiaonan, Mavis, Cory, Hernandez-Ilizaliturri, Francisco J., Zhang, Qunling
Publicado 2020

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma

por Xue, Kai, Wu, Ji-Chuan, Li, Xi-Ya, Li, Ran, Zhang, Qun-ling, Chang, Jin-Jia, Liu, Yi-Zhen, Xu, Chun-Hui, Zhang, Jia-Ying, Sun, Xiao-Jian, Gu, Juan J., Guo, Wei-Jian, Wang, Lan
Publicado 2021

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies

por Ghione, Paola, Gu, Juan J., Attwood, Kristopher, Torka, Pallawi, Goel, Shipra, Sundaram, Suchitra, Mavis, Cory, Johnson, Michael, Thomas, Roshneke, McWhite, Kenneth, Darrall, Andrea, DeMarco, Joseph, Kostrewa, Jessica, Mohr, Alice, Rivas, Leah, Neiders, Mirdza, Suresh, Lakshmanan, Segal, Brahm H., Griffiths, Elizabeth A., Ramsperger, Vince, Shen, Long, Hernandez-Ilizaliturri, Francisco J.
Publicado 2021

Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma

por Li, Xi-Ya, Wu, Ji-Chuan, Liu, Ping, Li, Zi-Juan, Wang, Yong, Chen, Bing-Yi, Hu, Cheng-Long, Fei, Ming-Yue, Yu, Peng-Cheng, Jiang, Yi-Lun, Xu, Chun-Hui, Chang, Bin-He, Chen, Xin-Chi, Zong, Li-Juan, Zhang, Jia-Ying, Fang, Ying, Sun, Xiao-Jian, Xue, Kai, Wang, Li, Chen, Shu-Bei, Jiang, Shi-Yu, Gui, Ai-ling, Yang, Ling, Gu, Juan J., Yu, Bao-Hua, Zhang, Qun-ling, Wang, Lan
Publicado 2022